Mission Statement
Organizational History
Overview of AATOD's Activities
Board of Directors
Message from the President

	Mark W. Parrino, M.P.A. PRESIDENT		Ron Jackson, M.S.W
	Ira J. Marion, M.A.		Edward G. Johnson, M.Ed, LPC
	George E. Stavros, M.D.		Janice F. Kauffman, R.N., M.P.H. C.A.S.
	Mike Rizzi		Jason Kletter, Ph.D.
	Jina K. Thalmann, LCSW		Shirley Linzy, R.N.
	Richard A. Bilangi, M.S.		Kate Mahoney, LCSW
	Roye T. Brown, M.S.		Brian McCarroll, M.S., D.O.
	Peter Coleman		Paul McLaughlin, M.A.
	Brian Crissman		Joel L. Millard, D.S.W., L.C.S.W.
	Eric Ennis, LCSW		Edward V. Ohlinger
	Steve Flora, B.S., AAP		Stacey Pearce
	Richard Froncillo, B.S., LCDS.		Keith E. Spare, M.S.
	James B. Graham
	Gregory Hardin, B.S., CADACII, ICADC
	Edward J. Higgins, M.A.
	Kenny House, LCAS

	Program Membership
	Individual Membership
	State Membership

Canon of Ethics
Membership Application
Membership Brochure

Projects/ Educational Training Events

Countering Opioid Stigma: Communicating Messages to Influence Public Perception
Clinicians Course
Hepatitis C
Prevalence of Prescription Opioid Abuse
Methadone Treatment in the Criminal Justice System
Upcoming Non-AATOD Events

Publications & Videos

Q&A

	Q's & A's from - "Regarding Methadone Treatment.and Other Pharmacotherapies." A Review. Committee of Methadone Program Administrators, Inc., New York, 1999.
	How can I locate a substance abuse treatment program in my area?
	Since all OTP’s need to be accredited through by CSAT/SAMHSA, what do I need to do to begin the process of getting accredited by a new program?
	What is the number of Opioid Treatment Programs (OTP) in the United States?
	Which states permit patients to use Medicaid to pay for methadone treatment services?

Glossary
More Information on Opioid Dependence

	Opioid Pharmacotherapy and Accreditation
	Fact Sheet: Methadone Research Findings
	Fact Sheet: Opioid Use and Dependence: Medication Assisted Treatment
	Comparison Chart of Heroin Dependence and Agonist Therapies

	QTc Interval Screening - AATOD Policy and Guidance Statement
	Dosage Induction with Methadone in the OTP
	AATOD's Five-Year Plan: 2007 - 2007
	Guidance Policy Statement for Infectious Disease Testing in OTPs
	AATOD Guidelines for Guest Medication
	Public Policy Statement on Office-based Opioid Agonist Treatment
	Shelf Life for Methadone Hydrochloride Products
	Training OTP Medical Practitioners
	Medical Maintenance Treatment and OBOT
	Guidelines for Involuntary Withdrawal from OTP Treatment Due to Non-Payment of Fees
	Expert Panel on Clinical Guidelines on LAAM
	AATOD's Five Year Plan for Methadone Treatment in the United States

	Why Methadone Treatment Works
	Drug Court Fact Sheet: Methadone Maintenance and Other Pharmacotherapeutic Interventions in the Treatment of Opioid Dependence

End of Year Reports 2005 | 2004 | 2003

Legislation

HBO Documentary Further Stigmatizes Methadone Treatment
	HBO Documentary Further Stigmatizes Methadone Treatment (AATOD Press Release – October 3, 2005)
	Model Letters to Patients - Joan E. Zweben, Ph.D. (Executive Director – The 14th Street   Clinic & Medical Group) - Michael Rizzi (President/CEO – CODAC Behavioral Healthcare)
	The Baron Edmond de Rothschild Chemical Dependency Institute of Beth Israel Medical Center Perspective – Written by Robert G. Newman, M.D. (Director)

Hurricane Katrina
	Letter from Todd Rosendale, M.A. (Public Health Advisor – CSAT/SAMHSA) regarding emergency medication for patients of programs impacted by Hurricane. (8/31/05).
	Guidance letter by Mark W. Parrino, M.P.A. (President – AATOD) to treatment programs through the country.
	Recommendations by Charles G. Curie, M.A., A.C.S.W. (Administrator – SAMHSA/CSAT) to treatment programs providing additional guidance in treating patients who have been displaced through Hurricane Katrina (September 9, 2005).
	Latest memo by Mark Parrino to the field, tracking which programs are treating patients and what services are being rendered. (September 28, 2005).

	DEA Drug Theft and Loss Report
Methadone Associated Mortality Report
	Methadone Deaths Not Linked to Misuse of Methadone from Treatment Centers (AATOD Press Release - Feb. 10, 2004)
	Remarks by Mark Parrino These remarks were made at the Pain and Chemical Dependency Conference on February 6, 2004, the location where the results of the report were unveiled.

International News

Archives

1998

	Imminent Changes for Our Field
	New Support for Methadone Maintenance Treatment through a Realistic National Drug Policy
	Neurobiology of Heroin Addiction and of Methadone Treatment
	Policy For Treating Methadone Maintained Patients in Private Medical Settings
	Buprenorphine and the Use of Clinically Effective Medications in Treating Chronic Opiate Dependence
	Ultra Rapid Detoxification
	Recommendations for Hepatitis Prevention and Treatment
	Reports from the States
	Increasing Support For Treatment in the Medical Establishment

1999

	News From the Front
	Association Survey Identifies Greater Numbers in Methadone Treatment
	1998 Methadone Maintenance Program and Patient Census in the U.S.
	Notice for Proposed Rule Making - Change in Federal Oversight for Methadone Treatment
	Narcotic Treatment Programs Best Practice Guidelines
	Drug Addiction and Treatment Act (S.324) (H.R.2634)
	Association Expands Its Training Course to Physicians and Clinicians in Methadone Treatment Programs
	Patient Recognition Ceremony
	Association Introduces Management Training Symposia
	Expanding Access to Medical Maintenance Treatment

2000

"Methadone Treatment: Our Vision for the Future"